Back to BIIB

BIOGEN INC. Total Liabilities & Equity 2008-2026 | BIIB

Beta

What is total liabilities & equity?

Total liabilities and stockholders' equity equals total assets, reflecting the fundamental accounting equation.

What is BIOGEN INC.'s current total liabilities & equity?

BIOGEN INC. (BIIB) annual total liabilities & equity for 2025 was $29.44B, a 4.96% increase from 2024. BIOGEN INC. total liabilities & equity for the quarter ending March 31, 2026 was $29.48B.

What was BIOGEN INC.'s total liabilities & equity in 2024?

BIOGEN INC. annual total liabilities & equity for 2024 was $28.05B, a 4.49% increase from 2023.

What was BIOGEN INC.'s total liabilities & equity in 2023?

BIOGEN INC. annual total liabilities & equity for 2023 was $26.84B, a 9.33% increase from 2022.

What is BIOGEN INC.'s 5-year total liabilities & equity CAGR?

BIOGEN INC. total liabilities & equity grew at a compound annual growth rate (CAGR) of 3.64% from FY2020 to FY2025, going from $24.62B to $29.44B over 5 years.

Total Liabilities & Equity History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Growing
CAGR+3.6%
FY2020
$24.62B
→
FY2025
$29.44B
080910111213141516171819202122232425
5 years selected
Total Liabilities & Equity History
PeriodValueChangeSource
FY2025$29.44B+5.0%10-K
FY2024$28.05B+4.5%10-K
FY2023$26.84B+9.3%10-K
FY2022$24.55B+2.8%10-K
FY2021$23.88B-3.0%10-K
FY2020$24.62B-9.6%10-K
FY2019$27.23B+7.7%10-K
FY2018$25.29B+6.9%10-K
FY2017$23.65B+3.4%10-K
FY2016$22.88B+17.3%10-K
FY2015$19.50B+36.3%10-K
FY2014$14.31B+20.7%10-K
FY2013$11.86B+17.1%10-K
FY2012$10.13B+11.9%10-K
FY2011$9.05B+11.8%10-K
FY2010$8.09B-5.4%10-K
FY2009$8.55B+0.9%10-K
FY2008$8.48B-10-K
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →